Delivery Order SPE2DB20D1100-SPE2DB24FB3W6

Award Date 4/19/24
Potential Completion Date 5/10/24
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,235.16, is for the delivery of the prescription medication Erleada 60 mg tablets. The contract has a firm fixed price pricing type and a completion date of May 19, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,106.87 firm-fixed-price contract is for the supply of 4,564,519,776 tablets of the prescription medication Erleada 60 mg. The contract has an ultimate completion date of May 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the medication Erleada 60 mg Tablet. The contract has a ceiling value of $7,306.27 and an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4,564,287,950 tablets of the pharmaceutical product ERLEADA 60 MG with a ceiling value of $14,213.74. The contract is a firm fixed price, delivery order type, with a completion date of May 6, 2024. There is no set-aside designation for this contract. Amerisourcebergen is a major...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,612.56, is for the delivery of 120 tablets of the drug ERLEADA 60 MG. The contract has a firm fixed price pricing type and a completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 IDC that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,558.78 firm fixed-price contract is for the supply of ERLEADA 60 MG TABLET UU 120S, a pharmaceutical product. The contract has a period of performance through February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,106.87 firm-fixed-price contract is for the delivery of 120 tablets of the prescription medication Erleada (60 mg) to support DoD and other government healthcare programs. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,352.49, is for the delivery of 4,568,076,666 units of the prescription medication Erleada 240 mg tablets. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of the drug Erleada (60 mg tablets) valued at $7,106.87. The award has an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order, which does not have a set-aside designation. The company also holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,950.04, is for the delivery of 120 tablets of the medication Erleada 60 mg. The contract is a firm fixed-price, delivery order type, with a completion date of February 13, 2023. It is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB3W6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 120 tablets of the prescription medication Erleada 60 mg. The contract has a firm fixed price of $7,106.87 and a completion date of May 10, 2024.

Amerisourcebergen is a major pharmaceutical distributor that holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. Amerisourcebergen's expertise in pharmaceutical distribution and existing government contracts position it well to efficiently fulfill this specific delivery order for the prescribed medication.

Generated 7/19/24, 9:31 AM